Of the tumors with available IHC data, aberrant CDH1 expression was observed in 10/49 (20.4%) of GS tumors, whereas aberrant p53 makes up 77/126 (61.1%) of CIN tumors. The gene discussed is TP53; the disease is cervical squamous intraepithelial neoplasia.